Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

Researchers from DZNE and Otto von Guericke University Magdeburg have identified individuals with increased risk for dementia ...

Gray stressed the effects are quite modest and only really effective at the really early stages of Alzheimer’s disease (and don’t work for vascular dementia ... as three months. The most commonly ...

Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled ...

Research shows that flavonoid-rich diets, including tea and red wine, are associated with a lower risk of dementia in ...

Alzheimer’s breakthrough after drug treatment success - Study found that the medication, called RI-AG03, was effective at ...

A BMJ investigation found seven of the eight doctors appointed by the US Food & Drug Administration (FDA) to review donanemab ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

CADASIL is a brain disease involving genetic mutations, stroke, and dementia. Learn about symptom progression and ongoing ...

More than 55 million people have dementia worldwide, over 60% of whom live in low- and middle-income countries (LMICs), according to the World Health Organization (WHO). Every year, there are nearly ...

Researchers from DZNE and Otto von Guericke University Magdeburg have identified individuals with increased risk for dementia ...